Phase 1 Endometrioid Ovarian Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

Endometrioid Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer

University of Colorado, Denver50 enrolled2 locationsNCT06856499

Recruiting

Phase 1

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Triple-Negative Breast CancerEndometrioid Ovarian CancerEpithelial Ovarian Cancer+2 more

Light Chain Bioscience - Novimmune SA70 enrolled7 locationsNCT05403554